Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 72

Results For "RIL"

1201 News Found

Quizartinib granted priority review in the U.S.
Drug Approval | October 26, 2022

Quizartinib granted priority review in the U.S.

Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone


Cadila Pharma's Esiloc wins
News | October 21, 2022

Cadila Pharma's Esiloc wins "Best Launch of the Year"

Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country


Mandaviya directs officials to focus on strengthening genome sequencing for early detection of variants
News | October 19, 2022

Mandaviya directs officials to focus on strengthening genome sequencing for early detection of variants

He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season


Piramal Pharma Solutions launches ADCelerate
News | October 13, 2022

Piramal Pharma Solutions launches ADCelerate

ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission


Marksans to acquire Tevapharm's bulk formulations business
News | October 12, 2022

Marksans to acquire Tevapharm's bulk formulations business

Plans to double its manufacturing footprint to bolster the growth


Entod introduces high performance eye supplements & eye drops Eyecirque
Healthcare | October 11, 2022

Entod introduces high performance eye supplements & eye drops Eyecirque

The eyecirque under eye skin brightening supplement is a unique composition of scientifically proven essential antioxidants, vitamins and minerals


Lupin Life announces association with Vikram Vedha as official energy partner
News | October 02, 2022

Lupin Life announces association with Vikram Vedha as official energy partner

Enriched with eight ayurvedic active ingredients like Ashwagandha, Shilajit, Shatavari, and Pippali, Be One works holistically to provide energy, build immunity and enable a healthy body and mind


Lupin receives warning letter from US FDA
Drug Approval | September 30, 2022

Lupin receives warning letter from US FDA

The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility


Emmes acquires Clinical Edge
News | September 30, 2022

Emmes acquires Clinical Edge

The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services


Julie Brown appointed as CFO of GSK
People | September 28, 2022

Julie Brown appointed as CFO of GSK

Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.